Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$17,500.00

Improving Fetal Health Outcomes: Investigating the Impact of Maternal Obesity and NAD+ Supplementation on Cardiometabolic Health of Offspring

EF 2023-24

Résumé
Obesity is a global health concern, with its rates tripling since 19751. Correspondingly, there has been a rise in maternal obesity2, increasing rates of adverse pregnancy outcomes and negatively impacting fetal development. Maternal obesity predisposes offspring to cardiometabolic diseases throughout their lifespan due to alterations during development3. While the way by which maternal obesity impacts offspring is not fully understood, evidence supports that an obesity-mediated chronic inflammatory state during pregnancy may lead to compromised development and function of the placenta4 - the vital organ of pregnancy responsible for all maternal-fetal exchange needed to support proper fetal growth. In non-pregnant populations, chronic inflammation is shown to dysregulated cellular energy metabolism processes via NAD+ depletion. Our group has likewise demonstrated this relationship between pro-inflammatory signaling, placental NAD+ depletion and compromised energy metabolism – leading to placental dysfunction and fetal growth restriction5. The current proposal will test the hypothesis that obesity-mediated inflammation will compromise placental energy metabolism processes, resulting in altered fetal organ development which pre-disposes the offspring to cardiometabolic disorders in later life. Using a mouse model of diet-induced gestational obesity, this proposed research project will specifically examine metabolic mechanisms through which obesity-mediated inflammation may impact fetal development, offspring growth outcomes and future cardiometabolic health. Additionally, this project will determine if these adverse health outcomes associated with maternal obesity can be minimized by rescuing placental energy metabolism via NAD+ supplementation throughout pregnancy.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
506070
Name
Gamelin Kao Jade
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Improving Fetal Health Outcomes: Investigating the Impact of Maternal Obesity and NAD+ Supplementation on Cardiometabolic Health of Offspring
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cardiometabolic Health; Fetal Development; Gestational Obesity; Placental Dysfunction
Abstract
Obesity is a global health concern, with its rates tripling since 19751. Correspondingly, there has been a rise in maternal obesity2, increasing rates of adverse pregnancy outcomes and negatively impacting fetal development. Maternal obesity predisposes offspring to cardiometabolic diseases throughout their lifespan due to alterations during development3. While the way by which maternal obesity impacts offspring is not fully understood, evidence supports that an obesity-mediated chronic inflammatory state during pregnancy may lead to compromised development and function of the placenta4 - the vital organ of pregnancy responsible for all maternal-fetal exchange needed to support proper fetal growth. In non-pregnant populations, chronic inflammation is shown to dysregulated cellular energy metabolism processes via NAD+ depletion. Our group has likewise demonstrated this relationship between pro-inflammatory signaling, placental NAD+ depletion and compromised energy metabolism – leading to placental dysfunction and fetal growth restriction5. The current proposal will test the hypothesis that obesity-mediated inflammation will compromise placental energy metabolism processes, resulting in altered fetal organ development which pre-disposes the offspring to cardiometabolic disorders in later life. Using a mouse model of diet-induced gestational obesity, this proposed research project will specifically examine metabolic mechanisms through which obesity-mediated inflammation may impact fetal development, offspring growth outcomes and future cardiometabolic health. Additionally, this project will determine if these adverse health outcomes associated with maternal obesity can be minimized by rescuing placental energy metabolism via NAD+ supplementation throughout pregnancy.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gamelin Kao, Jade
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~